IFNG and malignant colon neoplasm: Blockade of the checkpoint receptor TIGIT (T-cell immunoglobulin and immunoreceptor tyrosine-based inhibitory motif domain) can reverse the exhaustion of tumor-infiltrating NK cells and promote IFNγ production in a colon cancer-bearing mouse model [42].